News About: Goverment
KFDA say, no safety problems with plasma fraction products.
The KFDA responded to the issues raised by Rep. Ko Gyeong-wha concerning the HIV infected blood preparations in the market on Sept. 5 that the plasma fraction products of the HIV injected blood had no any safety probl...
Number of drug contra-indication extended to 200.
The MOHW extended number of drug indications currently from 172 to over 200 next year to ensure more of the drug safety along with the post controls and price review on the drugs and therapeutic materials on the marke...
HIV infected blood on market distribution.
The KFDA faced with a public criticism for which the HIV infected blood was distributed in the market and the materials were ordered to scrap on 3rd day upon their receipt of such report.
Rep. Ko Kyeong-wha of the ...
KHIDI and KOTRA to hold "BIO Korea 2006"
The Korea Health Industry Development Institute (KHIDI) and Korea International Trade Association (KITA) signed an agreement at the Trade Tower located at Samseong dong Seoul Korea on Sept. 5 for a joint auspice of "B...
Pharmacist legally to blame for dispensing wrong prescriptions.
When a pharmacist dispenses a wrong prescription issued by physicians, for instance, a prescription written with contra-indicated drugs, thus resulting in damages to the patient,
the pharmacist shall bear a partial ...
Drug review provisions massively to reshuffle.
Lawyer Park Jeong-il, a legal adviser for the KFDA, suggested his plans to reshuffle the relevant provisions of drug review in the meeting on the subject of the drug safety scheduled on Sept. 5.
The current provisi...
Good pharmacy practice system imminently needed.
Prof. Shin Hyeon-taek of Sukmyung Univ. college of pharmacy, suggested a future direction for the desirable pharmacy practices in his main thematic speech on the subject of "Problems, assessment and future measures af...
KFDA to review 1,101 biological drugs in 2006.
The KFDA announced on Aug. 31 that the total 1,101 products of 5 different biological drug groups and 3 parasitic animal drug groups should be reviewed in 2006 pursuant to the provision "Regulation pertaining to the d...
Korea and US FDA mutually to recognize GLP.The KFDA chief commissioner, Kim Jeong-sook visited to the U. S. FDA on Aug. 30 and met with Dr. Murray Lumpkin, the deputy commissioner of U. S. FDA. During her visit, they dis...
|
KFDA finally to approve 394 bulk drugs under DMF
The KFDA announced approval for the total 384 bulk products containing 75 ingredients including Acyclovir and Simvastatin to use through the implementation of the DMF (data master file) system.
Other 130 products w...
